| 7th Dec 2023 7:00 am |
RNS |
Q3 2023 U.S. Commercial Highlights |
| 27th Nov 2023 5:24 pm |
RNS |
PDMR Transaction Notification |
| 15th Nov 2023 7:30 am |
EQS |
Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team |
| 20th Oct 2023 11:45 am |
RNS |
Abstract to be presented at Healthcare Conference |
| 12th Oct 2023 7:00 am |
RNS |
Chief Financial Officer Transition |
| 3rd Oct 2023 3:00 pm |
RNS |
Result of REX Retail Offer |
| 3rd Oct 2023 7:00 am |
RNS |
Block listing Interim Return |
| 3rd Oct 2023 7:00 am |
RNS |
Completion of SWK Financing |
| 28th Sep 2023 12:50 pm |
RNS |
Successful completion of US$6.1m Equity Fundraise |
| 28th Sep 2023 7:02 am |
RNS |
REX Retail Offer |
| 28th Sep 2023 7:01 am |
RNS |
$20m secured debt facility &proposed equity raise |
| 28th Sep 2023 7:00 am |
RNS |
Interim results update and business update |
| 6th Sep 2023 7:00 am |
RNS |
Notice of Results and Change in reporting currency |
| 25th Jul 2023 9:45 am |
EQS |
Hardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gathering |
| 24th Jul 2023 2:27 pm |
RNS |
Holding(s) in Company |
| 20th Jul 2023 7:00 am |
RNS |
Business Update and U.S. Q2 2023 Highlights |
| 28th Jun 2023 5:30 pm |
RNS |
Results of 2023 Annual General Meeting |
| 16th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 15th Jun 2023 4:35 pm |
RNS |
Lapse of Offer |
| 15th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 15th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 14th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 14th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 13th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 13th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 12th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 12th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 9th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 9th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 8th Jun 2023 12:31 pm |
RNS |
Form 8.3 - Shield Therapeutics PLC (amendment) |
| 8th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 8th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 7th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 6th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 6th Jun 2023 10:10 am |
RNS |
Grant of share options to the CEO |
| 5th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 2nd Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 1st Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 1st Jun 2023 11:00 am |
RNS |
Holding(s) in Company |
| 1st Jun 2023 10:55 am |
RNS |
Holding(s) in Company |
